Breaking News

Over a week ago Show Full Stories X To view all stories in expanded form, please subscribe. Get Free Trial Send Info
RGEN Repligen $58.99 -0.55 (-0.92%) 07:36 02/21/19 02/21 07:36 02/21/19 07:36 Earnings	Repligen sees FY19 adj. EPS 81c-86c, consensus 85c » Sees FY19 revenue… Sees FY19 revenue $218M-$225M, consensus $217.25M. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb
RGEN Repligen $58.99 -0.55 (-0.92%) 07:35 02/21/19 02/21 07:35 02/21/19 07:35 Earnings	Repligen reports Q4 adj. EPS 21c, consensus 21c » Reports Q4 revenue… Reports Q4 revenue $51.85M, consensus $50.4M. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	21 Feb

Over a month ago
ALXN Alexion $108.41 0.62 (0.58%) , GSK GlaxoSmithKline $38.73 -0.09 (-0.23%) … 10:25 01/08/19 01/08 10:25 01/08/19 10:25 Conference/Events	JPMorgan to hold a conference » 37th Annual Healthcare… 37th Annual Healthcare Conference will be held in San Francisco on January 7-10 with webcasted company presentations to begin on January 8 at 10:30 am; not all company presentations may be webcasted.Webcast Link ALXN Alexion $108.41 0.62 (0.58%) GSK GlaxoSmithKline $38.73 -0.09 (-0.23%) PDCO Patterson Companies $21.00 0.26 (1.25%) ALDR Alder Biopharmaceuticals $10.89 -0.29 (-2.59%) BSX Boston Scientific $34.97 0.56 (1.63%) FOLD Amicus $11.02 0.06 (0.55%) AMR Alta Mesa Resources $1.32 0.03 (2.33%) SYNH Syneos Health $43.55 2.3 (5.58%) RHHBY Roche $0.00 (0.00%) CRL Charles River $116.05 3.5 (3.11%) BMY Bristol-Myers $47.81 -0.61 (-1.26%) ATRA Atara Biotherapeutics $32.13 -0.36 (-1.11%) MYL Mylan $30.36 0.61 (2.05%) CVS CVS Health $69.54 0.92 (1.34%) GBT Global Blood Therapeutics $42.82 -0.65 (-1.50%) TFX Teleflex $253.23 3.135 (1.25%) DOVA Dova Pharmaceuticals $8.52 -0.26 (-2.96%) GRTS Gritstone Oncology $18.33 -0.09 (-0.49%) RGEN Repligen $53.96 0.38 (0.71%) PTCT PTC Therapeutics $35.03 -0.68 (-1.90%) APLS Apellis $13.77 -0.08 (-0.58%) DGX Quest Diagnostics $83.38 0.75 (0.91%) XENT Intersect ENT $26.37 0.61 (2.37%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	08 Jan 08 Jan 08 Jan 09 Jan 09 Jan 14 Jan 15 Jan 16 Jan 17 Jan 18 Jan 21 Jan 24 Jan 27 Jan 28 Jan 01 Feb 04 Feb 06 Feb 10 Feb 14 Feb 18 Feb 18 Mar 18 May 20 May 28 May 30 Jun
ALXN Alexion $107.79 1.76 (1.66%) , GSK GlaxoSmithKline $38.82 0.2 (0.52%) … 08:24 01/08/19 01/08 08:24 01/08/19 08:24 Conference/Events	JPMorgan to hold a conference » 37th Annual Healthcare… 37th Annual Healthcare Conference will be held in San Francisco on January 7-10 with webcasted company presentations to begin on January 8 at 10:30 am; not all company presentations may be webcasted.Webcast Link ALXN Alexion $107.79 1.76 (1.66%) GSK GlaxoSmithKline $38.82 0.2 (0.52%) PDCO Patterson Companies $20.74 0.22 (1.07%) ALDR Alder Biopharmaceuticals $11.18 -0.6 (-5.09%) BSX Boston Scientific $34.41 0.21 (0.61%) FOLD Amicus $10.96 0.07 (0.64%) AMR Alta Mesa Resources $1.29 0.01 (0.78%) SYNH Syneos Health $41.25 1.29 (3.23%) RHHBY Roche $0.00 (0.00%) CRL Charles River $112.55 2.7 (2.46%) BMY Bristol-Myers $48.42 1.54 (3.29%) ATRA Atara Biotherapeutics $32.49 2.63 (8.81%) MYL Mylan $29.75 0.9 (3.12%) CVS CVS Health $68.62 1.84 (2.76%) GBT Global Blood Therapeutics $43.47 1.35 (3.21%) TFX Teleflex $250.10 -0.915 (-0.36%) DOVA Dova Pharmaceuticals $8.78 -0.04 (-0.45%) GRTS Gritstone Oncology $18.42 0.54 (3.02%) RGEN Repligen $53.58 2.76 (5.43%) PTCT PTC Therapeutics $35.71 -0.18 (-0.50%) APLS Apellis $13.85 -0.24 (-1.70%) DGX Quest Diagnostics $82.63 -0.14 (-0.17%) XENT Intersect ENT $25.76 -1.08 (-4.02%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	08 Jan 08 Jan 08 Jan 09 Jan 09 Jan 14 Jan 15 Jan 16 Jan 17 Jan 18 Jan 21 Jan 24 Jan 27 Jan 28 Jan 01 Feb 04 Feb 06 Feb 10 Feb 14 Feb 18 Feb 18 Mar 18 May 20 May 28 May 30 Jun

Over a quarter ago
RGEN Repligen $53.96 -3.31 (-5.78%) 15:08 12/17/18 12/17 15:08 12/17/18 15:08 Upgrade	Repligen rating change » Follow-up: Repligen… Follow-up: Repligen upgraded to Buy on valuation at CL King. As previously reported, CL King upgraded Repligen to Buy from Neutral with a $65 price target. Analyst David Westenberg said shares are now trading at a "reasonable" valuation with near-term drivers looking positive. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial

RGEN Repligen $54.01 -3.26 (-5.69%) 15:03 12/17/18 12/17 15:03 12/17/18 15:03 Upgrade	Repligen rating change at CL King » Repligen upgraded to Buy… Repligen upgraded to Buy from Neutral at CL King 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial
HOLX Hologic $39.82 -0.5 (-1.24%) , ILMN Illumina $307.95 -3.29 (-1.06%) … 08:37 11/15/18 11/15 08:37 11/15/18 08:37 Conference/Events	Deutsche Bank to hold a conference » 2018 Medtools &… 2018 Medtools & Diagnostics 1:1 Day will be held in New York on November 15. HOLX Hologic $39.82 -0.5 (-1.24%) ILMN Illumina $307.95 -3.29 (-1.06%) LMNX Luminex $25.94 -0.4 (-1.52%) MTD Mettler-Toledo $581.07 -8.265 (-1.40%) NEO NeoGenomics $16.01 -0.51 (-3.09%) NMRD Nemaura Medical $1.70 -0.08 (-4.49%) QGEN Qiagen $34.22 -0.655 (-1.88%) RGEN Repligen $63.74 -1.65 (-2.52%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 Nov 16 Nov 27 Nov 03 Dec 04 Dec
RGEN Repligen $67.74 -1.16 (-1.68%) 08:24 11/12/18 11/12 08:24 11/12/18 08:24 Downgrade	Repligen rating change at CL King » Repligen downgraded to… Repligen downgraded to Neutral from Buy at CL King. CL King analyst David Westenberg downgraded Repligen to Neutral from Buy. 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	15 Nov
POOL Pool Corp. $147.12 0.85 (0.58%) , TACT Transact Technologies $15.09 0.11 (0.73%) … 08:17 11/07/18 11/07 08:17 11/07/18 08:17 Conference/Events	Stephens to hold a conference » Stephens New York… Stephens New York Investment Conference will be held in New York on November 6-8 with webcasted company presentations to begin on November 7 at 8:15 am; not all company presentations may be webcasted. Webcast Link POOL Pool Corp. $147.12 0.85 (0.58%) TACT Transact Technologies $15.09 0.11 (0.73%) FIS FIS $104.68 0.64 (0.62%) FAF First American $45.46 0.63 (1.41%) RAMP LiveRamp $45.85 -0.29 (-0.63%) TECH Bio-Techne $172.32 2.05 (1.20%) ARCB ArcBest $41.08 -0.17 (-0.41%) SAFM Sanderson Farms $104.21 0.63 (0.61%) MRTN Marten Transport $19.83 0.09 (0.46%) RGEN Repligen $67.92 0.65 (0.97%) SUM Summit Materials $14.02 -0.45 (-3.11%) IRIX Iridex $5.40 -0.14 (-2.53%) SIEN Sientra $21.41 -0.1 (-0.46%) QNST QuinStreet $16.53 -0.75 (-4.34%) BLD TopBuild $51.94 2.53 (5.12%) RP RealPage $51.61 -1.3 (-2.46%) LAD Lithia Motors $85.59 -1.46 (-1.68%) R Ryder $56.62 -0.32 (-0.56%) CVTI Covenant Transportation $25.68 0.46 (1.82%) HABT Habit Restaurants $15.83 0.73 (4.83%) LGND Ligand $160.20 0.86 (0.54%) CSU Capital Senior Living $9.33 -0.21 (-2.20%) BIOS BioScrip $3.22 0.41 (14.59%) JKHY Jack Henry $150.88 1.24 (0.83%) RLGY Realogy $18.39 0.18 (0.99%) 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	07 Nov 07 Nov 08 Nov 08 Nov 08 Nov 08 Nov 12 Nov 13 Nov 13 Nov 13 Nov 15 Nov 15 Nov 15 Nov 26 Nov 03 Dec 10 Dec 13 Dec
RGEN Repligen $66.35 2.79 (4.39%) 07:44 11/05/18 11/05 07:44 11/05/18 07:44 Recommendations	Repligen analyst commentary at H.C. Wainwright » Repligen price target… Repligen price target raised to $60 from $49 at H.C. Wainwright. H.C. Wainwright analyst Raghuram Selvaraju raised his price target for Repligen to $60 but reiterates a Neutral rating on the name. Solid execution produced a "modest beat" in Q3, but the stock reaction may have been overdone, Selvaraju tells investors in a research note. He believes the stock "still looks expensive." 03/08/13 Wedge Partners 03/08/13 Credit Suisse 03/06/13 Citigroup 03/06/13 Barclays See Street Research during your Free Trial	06 Nov 15 Nov

On The Fly

News and insights, exclusive to thefly.com

20:25	Notable companies reporting before tomorrow's open»
19:06	Fly Intel: After Hours Movers»
13:27	Notable companies reporting before tomorrow's open»
13:27	Notable companies reporting after market close»
10:37	S&P continues climbing ahead of Fed rate meeting»

View all On The Fly Stories »

Upcoming
Events (10)

Today	ALIT	Alight - ALIT
Today	LEVI	Levi Strauss - LEVI
Today	EYEG	EyeGate Pharmaceuticals to Meet with FDA
Today		EyeGate Pharmaceuticals Meeting on de novo application strategy for its Ocular Bandage Gel (OBG) product with FDA
Today	JAZZ	PDUFA Date for Solriamfetol Extended
Today		PDUFA for NDA - First Review
Today		European Financials Conference
Today		Domopalooza 2019
Today		Atlanta Bank Summit
Today	IR ...	Global Industrials and EU Autos Conference

View all of today’s events »

Today’s
Syndicate (0)

No syndicate deals for your search.

View this week’s syndicate »

Get Full Fly Access

Breaking market intelligence sent straight to you: Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.

Up-to-date information on important industry events: Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.

News focused on the companies in your portfolio: Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.

14 Day Free Trial